Although the age range was wider than from our BC patient cohort, a comparison of levels of expression for HER2, CD24, and miR21 between healthy donors samples did not show statistically significant differences (p > 0.05, Supplementary Fig. 13. This evidence concerns the gene ERBB2 and breast cancer.